Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer
{{output}}
Targeted protein degradation (TPD) has emerged as a powerful strategy for eliminating disease-causing proteins. The prolyl isomerase Pin1 is an attractive therapeutic target given its oncogenic function. Here, we develop PIPWF, a novel peptide degrader that in... ...
